Device Trial Radar · NCT04787926
DuraLock-C Catheter Lock Solution
Last checked: Nov 20, 2026Latest source record: Jan 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
17
Actual
Start
Sep 23, 2021
Primary completion
Jun 1, 2023
Study completion Jun 1, 2023
Sponsor
- Lead sponsor
- Medical Components, Inc dba MedCompNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Syneos Health; Veeva Systems
- First posted
- Mar 9, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and performance of DuraLock-C 4.0%, 30.0%, and 46.7% for the maintenance of central venous catheter (CVC) patency in adult hemodialysis (HD) patients
Conditions
- Catheter-Related Infections
- Citrate Adverse Reaction
Interventions
Locking SolutionDevice
The total duration of the study treatment period will be 90 calendar days, from Visit 1 Pre-Instillation to the last study-related assessment. Two to 3 instillations (1 per lumen per visit) of DuraLock-C 4.0%, 30.0%, or 46.7% (equivalent to the catheter manufacturer's prescribed priming volume) will be instilled 1 to 3 days apart (with a HD schedule of 3 to 4 times per week); each instillation of CLS will remain in the CVC for approximately 24 to 72 hours ± 12 hours, based on their practice preferences. EOS will take place at the patient's next scheduled dialysis session.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Catheter PatencyTime frame: 90 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinique HEMERA Pays de Caux, 14 .A avenue Foch
Yvetot, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.